SEC Filings for NeuroBo Pharmaceuticals Inc. (NRBO)

$ 5.89   -0.07 (-1.17%) Volume: 1.72k 9:55 AM EDT 22-Sep-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities109/03/2020
3Initial statement of beneficial ownership of securities209/03/2020
8-KCurrent report pursuant to Section 13 or 15(d)709/02/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)6108/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)406/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)705/26/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)4205/20/2020
NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB305/18/2020
DEF 14AOther definitive proxy statements3704/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)6504/15/2020
424B5Prospectus [Rule 424(b)(5)]5904/15/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1304/01/2020
10-KAnnual report pursuant to Section 13 or 15(d)23303/30/2020
8-KCurrent report pursuant to Section 13 or 15(d)1103/30/2020
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)802/20/2020
<<
First
<
Prev
123456789101112131415